全文获取类型
收费全文 | 41789篇 |
免费 | 3463篇 |
国内免费 | 699篇 |
专业分类
耳鼻咽喉 | 240篇 |
儿科学 | 365篇 |
妇产科学 | 666篇 |
基础医学 | 2699篇 |
口腔科学 | 271篇 |
临床医学 | 5296篇 |
内科学 | 4132篇 |
皮肤病学 | 324篇 |
神经病学 | 793篇 |
特种医学 | 754篇 |
外科学 | 2806篇 |
综合类 | 6268篇 |
现状与发展 | 1篇 |
一般理论 | 4篇 |
预防医学 | 10191篇 |
眼科学 | 115篇 |
药学 | 3036篇 |
51篇 | |
中国医学 | 797篇 |
肿瘤学 | 7142篇 |
出版年
2023年 | 700篇 |
2022年 | 1174篇 |
2021年 | 1847篇 |
2020年 | 1868篇 |
2019年 | 1997篇 |
2018年 | 1970篇 |
2017年 | 1766篇 |
2016年 | 1434篇 |
2015年 | 1517篇 |
2014年 | 3681篇 |
2013年 | 3373篇 |
2012年 | 3006篇 |
2011年 | 2985篇 |
2010年 | 2281篇 |
2009年 | 2104篇 |
2008年 | 2375篇 |
2007年 | 1960篇 |
2006年 | 1616篇 |
2005年 | 1253篇 |
2004年 | 1116篇 |
2003年 | 951篇 |
2002年 | 560篇 |
2001年 | 584篇 |
2000年 | 459篇 |
1999年 | 367篇 |
1998年 | 312篇 |
1997年 | 284篇 |
1996年 | 276篇 |
1995年 | 220篇 |
1994年 | 206篇 |
1993年 | 155篇 |
1992年 | 114篇 |
1991年 | 120篇 |
1990年 | 89篇 |
1989年 | 82篇 |
1988年 | 60篇 |
1987年 | 63篇 |
1986年 | 45篇 |
1985年 | 120篇 |
1984年 | 142篇 |
1983年 | 104篇 |
1982年 | 134篇 |
1981年 | 93篇 |
1980年 | 90篇 |
1979年 | 80篇 |
1978年 | 48篇 |
1977年 | 30篇 |
1976年 | 39篇 |
1975年 | 28篇 |
1974年 | 26篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
2.
3.
4.
社会力量具备相应的经济基础和技术条件,对于公立互联网医院体系建设具有积极的促进作用。但是实践中仍然存在商业模式不完善、监管制度不健全等问题。基于经济学契约理论要义,提出在坚持激励与约束机制并举、平衡公私益关系的前提下,通过完善医保政策、构建互联网医疗服务价格分类管理机制来促进社会力量向医疗服务公益性目标回归,并通过构建完善的监督体制来约束部分社会力量的盲目逐利性行为。 相似文献
5.
6.
7.
《Transfusion and apheresis science》2022,61(4):103488
The COVID-19 pandemic caused by the SARS-CoV-2 virus has significantly disrupted and burdened the diagnostic workup and delivery of care, including transfusion, to cancer patients across the globe. Furthermore, cancer patients suffering from solid tumors or hematologic malignancies were more prone to the infection and had higher morbidity and mortality than the rest of the population. Major signaling pathways have been identified at the intersection of SARS-CoV-2 and cancer cells, often leading to tumor progression or alteration of the tumor response to therapy. The reactivation of oncogenic viruses has also been alluded to in the context and following COVID-19. Paradoxically, certain tumors responded better following the profound infection-induced immune modulation. Unveiling the mechanisms of the virus-tumor cell interactions will lead to a better understanding of the pathophysiology of both cancer progression and virus propagation. It would be challenging to monitor, through the different cancer registries, retrospectively, the response of patients who have been previously exposed to the virus in contrast to those who have not contracted the infection. 相似文献
8.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion. 相似文献
9.
10.
《Bulletin du cancer》2023,110(2):145-150